These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4709837)

  • 1. Differential effects of reserpine and alpha-methyl-P-tyrosine on norepinephrine and dopamine induced behavioral activity.
    Geyer MA; Segal DS
    Psychopharmacologia; 1973 Mar; 29(2):131-40. PubMed ID: 4709837
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for presynaptic dopamine mechanisms underlying amphetamine-conditioned locomotion.
    DiLullo SL; Martin-Iverson MT
    Brain Res; 1992 Apr; 578(1-2):161-7. PubMed ID: 1354997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of intraventricular dopamine on the spontaneous locomotor activity of rats pretreated with nialamide, reserpine, or alpha-methyl-p-tyrosine.
    Malec D; Kleinrok Z
    Pol J Pharmacol Pharm; 1973; 25(4):357-66. PubMed ID: 4774244
    [No Abstract]   [Full Text] [Related]  

  • 4. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of D-amphetamine by alpha-methyl-L-tyrosine: behavioral evidence for the participation of catecholamine stores and synthesis in the amphetamine stimulant response.
    Stolk JM; Rech RH
    Neuropharmacology; 1970 May; 9(3):249-63. PubMed ID: 4393182
    [No Abstract]   [Full Text] [Related]  

  • 6. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
    Segal DS; McAllister C; Geyer MA
    Pharmacol Biochem Behav; 1974; 2(1):79-86. PubMed ID: 4857225
    [No Abstract]   [Full Text] [Related]  

  • 7. Central actions of dopa and dopamine.
    Sourkes TL
    Rev Can Biol; 1972; 31():Suppl:153-68. PubMed ID: 4403289
    [No Abstract]   [Full Text] [Related]  

  • 8. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
    Jackson DM; Mohell N; Bengtsson A; Malmberg A
    Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
    Rech RH; Carr LA; Moore KE
    J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential behavioral responses of spontaneously hypertensive (SHR) and normotensive (WKY) rats to d-amphetamine.
    McCarty R; Chiueh CC; Kopin IJ
    Pharmacol Biochem Behav; 1980 Jan; 12(1):53-9. PubMed ID: 6445066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity.
    Andén NE; Strömbom U
    Psychopharmacologia; 1974; 38(2):91-103. PubMed ID: 4533319
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
    Dominic JA; Moore KE
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
    [No Abstract]   [Full Text] [Related]  

  • 13. Behavioral and norepinephrine-depleting effects of disulfiram in reserpine-pretreated rats.
    Moore KE; Rech RH
    Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):413-22. PubMed ID: 5364255
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the central effects of dopamine and epinine.
    Menon MK; Clark WG; Fleming RM; Yuen L
    Agressologie; 1973; 14(6):373-9. PubMed ID: 4802435
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of ECT on dopaminergic and noradrenergic mechanisms. I. Effect on the behavioural changes induced by reserpine, alpha-methyl-p-tyrosine or amphetamine.
    Papeschi R; Randrup A; Lai S
    Psychopharmacologia; 1974 Feb; 35(2):149-58. PubMed ID: 4856059
    [No Abstract]   [Full Text] [Related]  

  • 16. Central dopamine and noradrenaline receptor activity of the amines formed from m-tyrosine, alpha-methyl-m-tyrosine and alpha-methyldopa.
    Andén NE; Butcher SG; Engel J
    J Pharm Pharmacol; 1970 Jul; 22(7):548-50. PubMed ID: 4395068
    [No Abstract]   [Full Text] [Related]  

  • 17. Early behavioural effects of intraventricular administration of 6-hydroxydopamine in rat.
    Fibiger HC; Lonsbury B; Cooper HP; Lytle LD
    Nat New Biol; 1972 Apr; 236(68):209-11. PubMed ID: 4401617
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors.
    Starr MS; Starr BS
    Pharmacol Biochem Behav; 1989 May; 33(1):41-4. PubMed ID: 2571171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of locally applied dopamine to the nucleus accumbens on the motor activity of normal rats and following alpha-methyltyrosine or reserpine.
    Wachtel H; Ahlenius S; Andén NE
    Psychopharmacology (Berl); 1979 Jun; 63(3):203-6. PubMed ID: 113804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
    Ahlenius S
    Neuropharmacology; 1974 Aug; 13(8):729-39. PubMed ID: 4444759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.